Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental

Beni Lestari1,2, Rohmad Yudi Utomo3,4, Faaza Aulia Rahman2

  • 1Department Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.

Abstract

Insights

This study identified natural compounds like curcumin and quercetin that can trigger programmed cell death (apoptosis and pyroptosis) in neuroblastoma cells. These findings offer potential new therapeutic avenues for treating this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Neuroblastoma often evades apoptosis due to genetic mutations, necessitating novel therapeutic strategies.
  • Pyroptosis presents a promising cell death mechanism for neuroblastoma treatment.
  • Targeting gasdermin D (GSDMD) oligomerization is a key strategy to modulate pyroptosis.

Purpose of the Study:

  • To identify natural compounds that modulate pyroptosis by targeting GSDMD oligomerization.
  • To evaluate the cytotoxic effects and cell death mechanisms of identified compounds in neuroblastoma cells.

Main Methods:

  • Computational screening including pharmacophore fitting, molecular docking, and molecular dynamics simulations.
  • In vitro validation using WST-8 assays, Western blot, and immunofluorescence targeting caspase-1.
  • Drug-likeness analysis of natural compounds from the COCONUT database.

Main Results:

  • Five potent GSDMD oligomerization modulators were identified: quercetin, naringenin, hesperetin, curcumin, and galangin.
  • Curcumin, quercetin, and galangin exhibited significant cytotoxicity against GSDMD-expressing neuroblastoma cells.
  • Curcumin and galangin induced pyroptosis, while curcumin and quercetin also promoted apoptosis.

Conclusions:

  • Curcumin strongly regulates both apoptosis and pyroptosis.
  • Quercetin is a potent modulator of apoptosis, and galangin is a potent modulator of pyroptosis.
  • These compounds represent promising candidates for developing novel neuroblastoma therapeutics.

Related Concept Videos